The COVID Aftermath: Rising Immunoassay Interference in Diagnostic Immunoassays

NGS

2025 Outlook: Emerging Viruses & Next-Gen Respiratory DX

The 2025 flu season has been more intense than recent years, with elevated infection rates and notable pressure on healthcare...

Solving Enzyme Stability by Tackling Glycerol-Free Formulation Challenges

Imagine diagnostic assays that can be shipped and stored at room temperature, removing the need for freezing or refrigeration while...

The Growing Demand for Personalized Diagnostics: Navigating the Benefits and Limits of qPCR vs. NGS

The world of diagnostics is evolving rapidly, driven by the growing need for personalized healthcare solutions. For decades, qPCR has...

Next-Gen Synergies: Innovating POCT and NGS for Enhanced Molecular Diagnostics

In recent years, point-of-care testing (POCT) and next-generation sequencing (NGS) have undergone remarkable advancements, establishing themselves as fundamental tools in...